2025-07-28 - Analysis Report
Okay, here's an analysis of Eli Lilly and Co (LLY) based on the data you provided, presented in an English report format with a focus on key numbers and simple analysis.

**Eli Lilly and Co (LLY) Stock Analysis**

**1. Performance Overview**

*   **Ticker:** LLY
*   **Company Description:** Eli Lilly and Co is a global pharmaceutical company that discovers, develops, manufactures, and markets pharmaceutical products.

**Key Performance Metrics:**

*   **LLY Cumulative Return:** 249.28%
*   **S&P 500 (VOO) Cumulative Return:** 99.66%
*   **Absolute Spread:** 147.8
*   **Relative Spread:** 51.7 (This indicates that LLY's outperformance relative to VOO is positioned in the upper half of its historical range).

**Analysis:**

*   LLY has significantly outperformed the S&P 500 (VOO). The relative spread of 51.7 suggests that while LLY's outperformance is substantial, it's not at the very peak of its historical range.

**Alpha, Beta Analysis:**

| Year       | CAGR   | MDD    | Alpha   | Beta   | Cap(B) |
| :----------- | :----- | :----- | :------ | :----- | :------ |
| 2015-2017  | 10.0%  | 56.3%  | -19.0%  | 0.0    | 75.8   |
| 2016-2018  | 39.0%  | 58.6%  | 21.0%   | -0.1   | 103.9  |
| 2017-2019  | 50.0%  | 58.6%  | 20.0%   | 0.3    | 118.0  |
| 2018-2020  | 52.0%  | 58.6%  | 33.0%   | 0.1    | 151.6  |
| 2019-2021  | 106.0% | 60.6%  | 57.0%   | 0.2    | 248.0  |
| 2020-2022  | 98.0%  | 64.8%  | 96.0%   | 0.2    | 328.4  |
| 2021-2023  | 133.0% | 64.8%  | 115.0%  | 0.3    | 523.3  |
| 2022-2024  | 150.0% | 72.2%  | 124.0%  | 0.2    | 693.0  |
| 2023-2025  | 102.0% | 76.8%  | 51.0%   | 0.2    | 729.6  |

**Analysis:**

*   **CAGR:** Consistently high, showing strong growth in recent periods (2019-2024).
*   **MDD:** Relatively stable, indicating some consistency in risk.
*   **Alpha:** Generally positive and increasing, especially in recent years, indicating LLY's ability to generate returns independent of the market.
*   **Beta:** Low, suggesting LLY's price is not highly correlated with the overall market.
*   **Cap(B):** Significant increase, demonstrating substantial growth in market capitalization.

**2. Recent Stock Price Trends**

*   **Current Price:** 812.69
*   **Previous Close:** 805.43
*   **Change:** 0.9%
*   **5-Day Moving Average:** 791.13
*   **20-Day Moving Average:** 783.20
*   **60-Day Moving Average:** 773.53

**Analysis:**

*   The stock price is trending above all three moving averages (5, 20, and 60-day), which suggests an upward trend. The recent change of 0.9% indicates a positive movement.

**3. Market Risk Indicators and Expected Return**

*   **Market Risk Indicator (MRI):** 0.33 (Low Risk)
*   **RSI:** 61.67 (Close to overbought territory, but not yet extreme)
*   **PPO:** 0.35 (Positive, indicating an upward trend)
*   **Hybrid Signal:** cash_3%_Buy 80% of cash (60 shares - Caution - MRI:0.33)
*   **Recent (20-day) Relative Spread Change:** 0.6% (Short-term increase)
*   **Expected Return:** 151.3% (Long-term, relative to S&P 500)

**Analysis:**

*   The MRI suggests a low-risk environment for LLY. The RSI is approaching overbought levels, suggesting the stock may be due for a consolidation. The positive PPO supports the upward trend. The hybrid signal suggests buying with caution.  The high expected return indicates significant potential for long-term outperformance. The recent price change of 0.9%  reflects positive momentum.

**4. Recent News & Significant Events**

*   **[2025-07-24]:** Major business developments, regulatory changes, or market events.
*   **[2025-07-26]:** Analyst discussions on LLY's performance and outlook.
*   **[2025-07-27]:** Notable stock volatility.
*   **[2025-07-28]:** Experts highlight both risks and opportunities.

**Analysis:**

*   Recent news suggests that LLY is experiencing significant events that are influencing its stock price. Investors should monitor news and company announcements closely.

**5. Recent Earnings Analysis**

| Date       | EPS  | Revenue      |
| :----------- | :--- | :------------- |
| 2025-05-01 | 3.07 | 12.73 B$       |
| 2024-10-30 | 1.08 | 11.44 B$       |
| 2024-08-08 | 3.29 | 11.30 B$       |
| 2024-04-30 | 2.49 | 8.77 B$        |
| 2025-05-01 | 2.49 | 8.77 B$        |

**Analysis:**

*   The EPS and revenue numbers suggest a recent upward trend in performance.  The increasing revenue and EPS indicate strong growth.

**6. Financial Information**

**Revenue and Profitability:**

| Quarter    | Revenue   | Profit Margin |
| :----------- | :-------- | :-------------- |
| 2025-03-31 | $12.73B | 82.53%        |
| 2024-12-31 | $13.53B | 82.24%        |
| 2024-09-30 | $11.44B | 81.02%        |
| 2024-06-30 | $11.30B | 80.80%        |
| 2024-03-31 | $8.77B  | 80.91%        |

**Capital and Profitability:**

| Quarter    | Equity    | ROE     |
| :----------- | :-------- | :------ |
| 2025-03-31 | $15.76B | 17.50% |
| 2024-12-31 | $14.19B | 31.07% |
| 2024-09-30 | $14.24B | 6.81%  |
| 2024-06-30 | $13.56B | 21.88% |
| 2024-03-31 | $12.81B | 17.51% |

**Analysis:**

*   Revenue has been increasing, demonstrating growth.  Profit margins are very high, indicating strong profitability. Equity is increasing, suggesting financial strength. ROE is fluctuating, but generally strong.

**7. Overall Summary**

Eli Lilly and Co (LLY) is exhibiting strong performance characteristics:

*   **Outperformance:**  Significantly outperforming the S&P 500.
*   **Growth:** Strong revenue and earnings growth.
*   **Profitability:**  High profit margins.
*   **Low Risk:**  As indicated by the Market Risk Indicator.
*   **Positive Trend:** The stock is currently in an upward trend.

**Considerations:**

*   **RSI:** Approaching overbought levels.
*   **Recent News:** Monitor news and company announcements for potential impacts.
*   **Volatility:** The recent news indicates the potential for increased stock volatility.

**Recommendation:**

Based on the analysis, LLY appears to be a strong investment. However, investors should be mindful of the RSI approaching overbought levels and monitor recent news for any potential risks. The Hybrid Signal suggests a cautious buying approach. Long-term investors could consider accumulating shares, but short-term traders should be aware of potential volatility and consolidation.
